Edition:
United Kingdom

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

22.39USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$22.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,271
52-wk High
$40.56
52-wk Low
$19.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
FY 2015 Dec '15 12.52 -0.087
Sep '15 12.50 0.032
Jun '15 12.36 -0.085
Mar '15 12.93 0.068
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 10.98 12.60 7.15 7.04
Quarter Ending Mar-18 2 9.77 12.50 7.05 --
Year Ending Dec-17 7 49.08 50.70 45.24 47.16
Year Ending Dec-18 7 47.02 50.50 28.18 39.14
Earnings (per share)
Quarter Ending Dec-17 8 -0.56 -0.45 -0.82 -0.30
Quarter Ending Mar-18 4 -0.57 -0.45 -0.78 --
Year Ending Dec-17 8 -1.90 -1.74 -2.20 -0.80
Year Ending Dec-18 8 -2.42 -1.58 -2.97 -1.62
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 16.46 100.67 5.40
Price to Book (MRQ) -- 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 38.46 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3.56 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 1.53 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -927.87 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -792.05 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 1.34 5.36 2.98
LT Debt to Equity (MRQ) -- 18.92 11.56
Total Debt to Equity (MRQ) -- 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -45.39 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -46.57 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -46.88 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -46.89 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 674,533 25,314,503 864,673,366
Net Income/Employee (TTM) -316,293 3,332,048 101,717,513
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.54 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.54 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -63.77 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -- 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -0.92 -0.88 --
EPS (TTM) % -333.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.73%
# of Holders: 121
Total Shares Held: 10,066,482
3 Mo. Net Change: 3,105,737
# New Positions: 31
# Closed Positions: 4
# Increased Positions: 79
# Reduced Positions: 15
# Net Buyers: 64
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.